Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).
about
Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectivesHow to Create Evidence for the Integration of Local and Locoregional Treatments in Future Oncological Treatment Concepts?Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization)Evolving ablative therapies for hepatic malignancyCancer concepts and principles: primer for the interventional oncologist-part IIHow to select the optimal treatment for first line metastatic colorectal cancerLocal Ablation for Solid Tumor Liver Metastases: Techniques and Treatment EfficacyColorectal Liver Metastases: A Critical Review of State of the ArtFirst clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal.Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.Patterns of complications following intraoperative radiofrequency ablation for liver metastases.Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience.Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single centerPatterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.Resection of the Primary Tumor in Stage IV Colorectal Cancer: When Is It Necessary?Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Minimally Invasive Liver Surgery for Hepatic Colorectal MetastasesImpact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases.Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancerLocoregional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement.Understanding the current status of image-guided ablation for metastatic colorectal disease.Stereotactic body radiotherapy: a critical review for nonradiation oncologists.Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.Intraductal radiofrequency ablation for management of malignant biliary obstruction.Liver-directed therapies in metastatic colorectal cancer.Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases.Clinical trials of interventional oncology-moving from efficacy to outcomes.
P2860
Q26738434-92B24E76-3811-431D-A703-76661B4E0B85Q26796520-6FDD893A-C5EA-49AA-8A5A-CC77AFF04388Q26796524-28142C61-3E15-4AD2-A805-D795D380E7D8Q27002551-AE775844-5216-4805-9BD9-9A8D3CC0D6D3Q27010961-2965CB4C-5775-4DCB-9C73-B07C3ED9B655Q27026516-938151BF-E33C-482E-AB1B-C8C1C9214577Q28067030-67770C7F-D3EA-43FE-A480-CECE76FDB0B0Q28070400-6EF29517-FA0E-4EEF-9CF4-DC24B377C641Q30417323-1B5CD919-8A55-44E7-B012-DB0CE39D7BFDQ30657649-3C07B308-C577-4196-8726-5E01D5DA6F0EQ33555345-683D1E97-1B75-465A-9958-9013DC303E18Q33614301-24D545C9-5D66-40AA-AD73-6AC81A572939Q33695043-21FFC987-E01D-47FC-B017-8F0B625CBD8FQ33720942-035915E6-26A3-4A2C-9FAD-856E51A74922Q33906344-D39F6EB2-D505-451A-BA38-341A56415B49Q34653647-F18C3AA1-5AD6-4EAC-9BDE-104A6386651EQ34680997-15218951-D6B9-4305-AAF7-6408AF2EBA15Q35805855-03C189B2-DB71-46A7-9529-535D5B880108Q35842973-F91B78AE-08FD-439D-9DA6-E9BF6FC93797Q35940367-9AF3FBB2-115E-4116-A8C5-C1E6D73067E7Q35994298-F9D2E57C-49AB-4C4C-9508-61B99ABB74CEQ36061491-B6064BF0-BBE2-49BF-895A-510287D4DADAQ36083102-74597DA9-E873-46C1-987B-A2FBF29AE765Q36143931-5496E671-4632-4958-9BE7-859ECEB13824Q36258276-6C6E6B67-4712-4818-8ECE-A45D3D11BD8CQ36344123-3FEAEC00-3A90-4D49-870E-0E3099159B1CQ36371089-96D727AE-AD0B-41A3-9530-6EC2E4718DC7Q36392298-80281020-6F1C-4971-BA0A-D8EBC91E1CAFQ37207682-DBCA7A42-922F-43AC-AAD7-F226C1D8575DQ37427913-5CBC17F7-D7BC-41D3-BB48-62CDD4FD862AQ37677524-74372B08-5477-4E18-A83D-1D944427AAC0Q38072440-C6830A64-D31C-428C-A0AF-A9583542C5BCQ38114316-FDA44C3A-537C-4812-8C14-BC2FB3C47DC8Q38175120-FFC1F4F6-B33B-4D1F-AE04-A368F12DC1C4Q38191225-2A906A7A-B2F6-466E-AA60-243E807DD9A5Q38196360-61D51666-0E38-4597-9B52-AB07465F753AQ38218337-00C2E44C-AE8C-49F7-ABBE-70B0A3ABA2B3Q38256165-49285795-0452-4741-BEBB-FE187DE0AC8AQ38283660-82D98C61-685C-4D50-A1D8-F16C0BC1230FQ38285540-8A6C0538-EB33-4CED-B91A-752529FC9929
P2860
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Radiofrequency ablation combin ...... phase II study (EORTC 40004).
@ast
Radiofrequency ablation combin ...... phase II study (EORTC 40004).
@en
type
label
Radiofrequency ablation combin ...... phase II study (EORTC 40004).
@ast
Radiofrequency ablation combin ...... phase II study (EORTC 40004).
@en
prefLabel
Radiofrequency ablation combin ...... phase II study (EORTC 40004).
@ast
Radiofrequency ablation combin ...... phase II study (EORTC 40004).
@en
P2093
P2860
P356
P1433
P1476
Radiofrequency ablation combin ...... phase II study (EORTC 40004).
@en
P2093
B Nordlinger
E Van Cutsem
EORTC Gastro-Intestinal Tract ...... inical Study Group (NCRI CCSG)
F Van Coevorden
I Borel-Rinkes
J A Ledermann
J P E N Pierie
P2860
P304
P356
10.1093/ANNONC/MDS053
P577
2012-03-19T00:00:00Z